Literature DB >> 3274312

Role of bile and bile salts on cyclosporine absorption in dogs.

B G Ericzon1, S Todo, S Lynch, I Kam, R J Ptachcinski, G J Burckart, D H Van Thiel, T E Starzl, R Venkataramanan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3274312      PMCID： PMC2975448     

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  5 in total

1.  Biliary Excretion of Cyclosporine in Liver Transplant Patients.

Authors:  R Venkataramanan; T E Starzl; S Yang; G J Burckart; R J Ptachcinski; B W Shaw; S Iwatsuki; D H Van Thiel; A Sanghvi; H Seltman
Journal:  Transplant Proc       Date:  1985-02       Impact factor: 1.066

Review 2.  Pharmacokinetics and monitoring of cyclosporine following orthotopic liver transplantation.

Authors:  R Venkataramanan; G J Burckhart; R J Ptachcinski
Journal:  Semin Liver Dis       Date:  1985-11       Impact factor: 6.115

3.  Cyclosporine monitoring in liver transplant patients.

Authors:  W Andrews; S Iwatsuki; B W Shaw; T E Starzl
Journal:  Transplantation       Date:  1985-03       Impact factor: 4.939

4.  Cyclosporine kinetics in renal transplantation.

Authors:  R J Ptachcinski; R Venkataramanan; J T Rosenthal; G J Burckart; R J Taylor; T R Hakala
Journal:  Clin Pharmacol Ther       Date:  1985-09       Impact factor: 6.875

Review 5.  Clinical pharmacokinetics of cyclosporin.

Authors:  R J Ptachcinski; R Venkataramanan; G J Burckart
Journal:  Clin Pharmacokinet       Date:  1986 Mar-Apr       Impact factor: 6.447
  5 in total
  9 in total

1.  Tube choledochoureterostomy: a simple method for bile diversion.

Authors:  H Furukawa; S Todo; O Imventarza; Y M Wu; T E Starzl
Journal:  J Invest Surg       Date:  1990       Impact factor: 2.533

2.  The effect of food and bile acid administration on the relative bioavailability of cyclosporin.

Authors:  A Lindholm; S Henricsson; R Dahlqvist
Journal:  Br J Clin Pharmacol       Date:  1990-05       Impact factor: 4.335

3.  Biopharmaceutical aspects of FK-506.

Authors:  R Venkataramanan; V S Warty; M A Zemaitis; A T Sanghvi; G J Burckart; H Seltman; S Todo; L Makowka; T E Starzl
Journal:  Transplant Proc       Date:  1987-10       Impact factor: 1.066

4.  Cyclosporine pharmacokinetics in liver transplant recipients: evaluation of results using both polyclonal radioimmunoassay and liquid chromatographic analysis.

Authors:  J M Tredger; J Grevel; N Naoumov; C M Steward; A A Niven; B Whiting; R Williams
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

5.  The effect of bile duct ligation and bile diversion on FK506 pharmacokinetics in dogs.

Authors:  H Furukawa; O Imventarza; R Venkataramanan; M Suzuki; Y Zhu; V S Warty; J Fung; S Todo; T E Starzl
Journal:  Transplantation       Date:  1992-04       Impact factor: 4.939

6.  Absorption of cyclosporin from conventional and new microemulsion oral formulations in liver transplant recipients with external biliary diversion.

Authors:  A K Trull; K K Tan; L Tan; G J Alexander; N V Jamieson
Journal:  Br J Clin Pharmacol       Date:  1995-06       Impact factor: 4.335

7.  Intraindividual variability in the relative systemic availability of cyclosporin after oral dosing.

Authors:  A Lindholm; S Henricsson; M Lind; R Dahlqvist
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

Review 8.  Clinical pharmacokinetics in organ transplant patients.

Authors:  R Venkataramanan; K Habucky; G J Burckart; R J Ptachcinski
Journal:  Clin Pharmacokinet       Date:  1989-03       Impact factor: 6.447

9.  Cyclosporin A pharmacokinetics in liver transplant recipients in relation to biliary T-tube clamping and liver dysfunction.

Authors:  N V Naoumov; J M Tredger; C M Steward; J G O'Grady; J Grevel; A Niven; B Whiting; R Williams
Journal:  Gut       Date:  1989-03       Impact factor: 23.059
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.